By: Adam Feuerstein | 01/10/14 - 11:56 AM ESTAs if healthcare investors need more reasons to pay attention to next week's J.P. Morgan Healthcare Conference, biotech stocks outperform the S&P 500, historically, during the week of the confab.
Take a look at the chart included in a preview note published by J.P. Morgan's analysts. The data, itself, come from Bloomberg.J.P. Morgan:
I would have preferred to see the analysis conducted with the more inclusive Nasdaq Biotechnology Index (NBI) because the BTK tracks fewer stocks.
We assessed BTK performance relative to the S&P 500 during the week of the J.P. Morgan Healthcare Conference over the past 13 years. We observed that 85% of the time (all but 2 years), the BTK outperformed the S&P 500. From Monday to Friday during the week of the conference, the BTK increased on average by 3.0%, vs. flat S&P 500. Thus, the BTK outperformed the S&P 500 by ~2.9% on average during the week of the conference over the past 13 years
-- Reported by Adam Feuerstein in Boston.Follow Adam Feuerstein on Twitter.
07/08/14 - 09:52 AM EDT
07/08/14 - 09:14 AM EDT
07/07/14 - 02:49 PM EDT
07/07/14 - 11:23 AM EDT
06/25/14 - 01:05 PM EDT
07/10/14 - 09:15 AM EDT
07/09/14 - 11:12 AM EDT
07/08/14 - 11:16 AM EDT
07/07/14 - 12:45 PM EDT
07/06/14 - 11:59 AM EDT
Access the tool that DOMINATES the Russell 2000 and the S&P 500.